InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Uihlein Richard E, Director. Officer active across 1 company, notably Galectin Therapeutics INC. Aggregated, 2 disclosures have been logged. Activity tracked since 24 January 2022. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
17,677 shares@ US$1.980.022% mcap50.0% of flowCommon StockSEC:0001133416-22-000043:0
17,677 shares@ US$1.98100.0% of flowCommon StockSEC:0001133416-22-000043
2 of 2 declarations
About Uihlein Richard E
Richard E. Uihlein is a Director at GALECTIN THERAPEUTICS INC. He brings extensive experience in corporate governance and strategy. As a director, Richard contributes to the direction and oversight of the company's activities, ensuring they align with best practices and strategic objectives. His expertise is a valuable asset for GALECTIN THERAPEUTICS INC.
